Skip to main content

KUMU KAHUA

Kumu Kahua is a smallish community theater located in middle downtown Honolulu.  It features shows by local Hawaii-based playwrights featuring themes and stories of the people of the state.  Hawaiian Creole English, also known as pidgin, is liberally used.

It was founded 51 years ago by graduate students of the University of Hawaii to highlight locally-written experimental works.  The organizers were granted not-for-profit status 40 years ago and in 1994 the Hawaii State Legislature awarded the group its current 100-seat playhouse on prime commercial property at 46 Merchant Street.

Kumu Kahua Theatre also offers classes in acting and writing, sponsoring an annual playwriting contest in conjunction with the University of Hawaii Theatre Department.  Just last week paid more than $500 for seats to Beautiful at the Blaidell Concert Hall.  Two seats at Kumu cost $40, but was given to us.

So off we went Sunday afternoon to watch Who You Again?, written by Ryan Okinaka (middle), directed by Denny Hironaga (right), with assistant direction by Elexis Draine (left).

Ryan prefers to go by the name of Oki, as in Oki-naka.  Born and raised in Honolulu, he also has been in Improv comedy for  a decade.  Acted on TV in Doogie Kamealoha and Hawaii Five-O.

The primary actors were Karen Kuioka Hironaga (yes, wife of the director, on the left), Kati Kuroda (center) and Kaipo Dudoit.  They were all terrific.

As you have by now no doubt figured out, the play is about dementia.  Oki's gramdmother had this condition and did not know her grandson.  He said, you can find beauty in the great sorrows of life.  I too closely identified with the affected grandmother played by Kuroda, for I sometimes felt she was playing me.

This is an opportunity to provide another eclectic review, Photocopier, the first Indonesian film I have ever seen.  It premiered at the 2021 Busan International Film Festival, winning a record 12 awards out of 17 nominations, including Best Picture and Best Director.  Incredibly, Rotten Tomatoes reviewers bestowed a 100% rating.  Here is a snippet of a Busan review:

This compelling tech-thriller unpicks the inequalities of Indonesia's conservative society, both economically and sexually, to deliver a powerful commentary on the considerable cost of pursuing the truth.

I won't say much more except to indicate that you can find this film on Netflix.  I can, though, report on my research about the Cinema of Indonesia:

  • They have been producing films since 1910.
  • Released 230 films in 2019, but hit hard by the pandemic.  Photocopier was made during this period.
  • There are more than 3,000 screens in their movie theaters, and one company has plans to open 300 cinemas with 2,000 screens across 85 cities over the next decade.
  • Of course new cinemas are now equipped with Dolby Atmos, IMAX and IMAX with Laser, with mobile ticketing.
  • Theaters shave luxury facilities, with seats resembling an airplane business class sofa with blankets.
  • Rated as the top Indonesian film of all-time is the 2008 Laskar Pelangi (The Rainbow Troops), with a Rotten Tomatoes audience rating of 91.

- 

Comments

Popular posts from this blog

HONOLULU TO SEATTLE

The story of the day is Hurricane Milton, now a Category 4 at 145 MPH, with a track that has moved further south and the eye projected to make landfall just south of Sarasota.  Good news for Tampa, which is 73 miles north.  Milton will crash into Florida as a Category 4, and is huge, so a lot of problems can still be expected in Tampa Bay with storm surge.  If the eye had crossed into the state just north of Tampa, the damage would have been catastrophic.  Milton is a fast-moving storm, currently at 17 MPH, so as bad as the rainfall will be over Florida, again, a blessing.  The eye will make landfall around 10PM EDT today, and will move into the Atlantic Ocean north of Palm Bay Thursday morning. My first trip to Seattle was in June of 1962 just after I graduated from Stanford University.  Caught a bus. Was called the  Century 21 Exposition .  Also the Seattle World's Fair.  10 million joined me on a six-month run.  My first. These a...

A NEXT COVID SUBVARIANT?

By now most know that the Omicron BA.5 subvariant has become the dominant infectious agent, now accounting for more than 80% of all COVID-19 cases.  Very few are aware that a new one,   BA.4.6,  is sneaking in and steadily rising, now accounting for 13% of sequenced samples .  However, as BA.4.6 has emerged from BA.4, while there is uncertainty, the scientific sense is that the latest bivalent booster targeting BA.4 and BA.5 should also be effective for this next threat. One concern is that Evusheld--the only monoclonal antibody authorized for COVID prevention in immunocompromised individuals--is not effective against BA.4.6.  Here is a  reference  as to what this means.  A series of two injections is involved.  Evusheld was developed by British-Swedish company AstraZeneca, and is a t ixagevimab  co-packaged with  cilgavimab . More recently, Los Angeles County reported on  subvariant BA.2.75.2 . which Tony Fauci termed suspicio...

IS FLORIDA AGAIN THREATENED BY A MEGA TSUNAMI FROM LA PALMA?

 From the morning  New York Times : Here is a graph comparing average daily COVID-19 deaths/100,000 people, and the USA is doing something really wrong: The difference between our country and Europe is that we have flubbed the availability of cheap and ubiquitous at-home RAPID testing.  They have covered this base. There are two obvious problems: The FDA is much too bureaucratic about quickly approving anything related to this pandemic, including testing. We seem stuck with the test that takes one to several days to get your result. The good news is that the Biden administration has finally realized this problem and through executive order hope to soon flood the market with take home testing that at first will be subsidized to make it affordable. Now, on to getting everyone vaccinated, especially 5-11 years olds ( and we are close to getting to making this happen ), the undereducated and Republicans.  What to do about the latter two? The other concern is whether we a...